Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Mark Duper who wrote (33884)	4/30/1999 2:08:00 PM
From: Pluvia	Read Replies (2) \| Respond to of 122087

We need to close with a new trans high - we broke it intraday.... After we break/close at a new high I expect a significant rally...

To: Mark Duper who wrote (33884)	4/30/1999 2:11:00 PM
From: If only I'd held	Respond to of 122087

DIGE, just spoke with the company. Actually, they are right around the corner from me. Anyway, the tests are sold 96 at a time for a cost of $1,890.00. Divided, that comes to $19.6875 per test. So my estimate of $20 per test was not far off. The girl said they are going quick and that they are being recommended with every pap smear conducted. 50 million papsmears are conducted in the U.s evry year. 50,000,000 x $19.6875 per test = $984,375,000 per year in sales. Total outstanding shares of DIGE are 14.3 million. 14.3 million x $40 per share = $572,000,000 market cap. That's just over .5 x sales. Seems pretty cheap if you use forward looking projections. They have other products in the works also. I am very interested in the opinions of others, since I tripled my position in this company this morning.